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Abstract
Background: Transgenic mice with low levels of global insulin-like growth factor-I (IGF-I) throughout their life span,
including pre- and postnatal development, have increased longevity. This study investigated whether specific deficiency of
liver-derived, endocrine IGF-I is of importance for life span.
Methods and Findings: Serum IGF-I was reduced by approximately 80% in mice with adult, liver-specific IGF-I inactivation
(LI-IGF-I
-/- mice), and body weight decreased due to reduced body fat. The mean life span of LI-IGF-I
-/- mice (n=84)
increased 10% vs. control mice (n=137) (Cox’s test, p,0.01), mainly due to increased life span (16%) of female mice [LI-IGF-
I
-/- mice (n=31): 26.761.1 vs. control (n=67): 23.060.7 months, p,0.001]. Male LI-IGF-I
-/- mice showed only a tendency for
increased longevity (p=0.10). Energy expenditure, measured as oxygen consumption during and after submaximal exercise,
was increased in the LI-IGF-I
-/- mice. Moreover, microarray and RT-PCR analyses showed consistent regulation of three genes
(heat shock protein 1A and 1B and connective tissue growth factor) in several body organs in the LI-IGF-I
-/- mice.
Conclusions: Adult inactivation of liver-derived, endocrine IGF-I resulted in moderately increased mean life span. Body
weight and body fat decreased in LI-IGF-I
-/- mice, possibly due to increased energy expenditure during exercise. Genes
earlier reported to modulate stress response and collagen aging showed consistent regulation, providing mechanisms that
could underlie the increased mean life span in the LI-IGF-I
-/- mice.
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Introduction
Insulin-like growth factor-I (IGF-I) is among the relatively few
factors that regulate life span. Caenorhabditis elegans (C. elegans,a
nematode) and Drosophila melanogaster (fruit fly) have common
signaling pathways for IGF-I and insulin, and disruption of IGF-I/
insulin signaling in these species increases longevity [1–4]. Mice
have separate receptors for IGF-I and insulin, and longevity
increases in several mouse strains with low global activity of the
growth hormone (GH)/IGF-I axis. Spontaneous mutations in
Prop-1 (Ames dwarf mice) [5] and Pit-1 (Snell dwarf mice) [6]
result in impaired pituitary gland development, low GH secretion,
and increased life expectancy [5,6]. Life expectancy increases in
mice with deficient GH-releasing hormone receptor (Ghrhr
lit/lit
mice) [6], GH receptor null mice [7], and mice that are
heterozygous in terms of inactivation of the IGF-I receptor in
total body (Igf1r
+/2 mice) [8]. Longevity also increases in mouse
models with reduced IGF-I bioavailability due to knockout of the
IGF binding protein (IGFBP) specific protease PAPP-A [9], and in
mice with defective IGF-I signaling downstream of the IGF-I
receptor such as mice lacking the IGF-I receptor substrate p66
shc
[10] and mice that overexpress KLOTHO [11]. A cross-sectional
study of 31 strains of mice detected an inverse correlation between
plasma IGF-I levels at 6 months and median lifespan [12]. In
terms of the brain, the role of IGF-I is complex and the effects of
IGF-I on lifespan and neuronal function can be uncoupled to some
extent [13]. In mice, administration of IGF-I may provide
protection from neurodegeneration [14] while heterozygous
brain-specific IGF-I receptor knockout enhances longevity [15].
The rate of aging is plastic and mutations in genes influencing
endocrine signaling, fertility, stress responses, metabolism and
telomeres can affect life span in model organisms [16,17].
Reduced body weight may participate importantly in the increased
life span of long-lived, GH-deficient Ames dwarf mice, as could
low fertility [18]. However, several studies have demonstrated that
reduced body size or fertility is not required for increased life span
in mice with low GH/IGF-I activity [8,18]. Reduced activity of
nutrient-sensing pathways, such as attenuated IGF-I signaling,
may mediate some of the anti-aging effects of dietary restriction in
mice [19]. However, the prolonging effect on life span by low food
intake is partly independent of IGF-I as caloric restriction prolongs
life span even further in Ames dwarf mice [20]. Furthermore,
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oxidative species (ROS) and oxidative damage [21]. In C. elegans
and Drosophila melanogaster with low IGF-I/insulin activity
[17,22,23], as well as in Igf1r
+/2 mice [8] and mice lacking the
IGF-I receptor substrate p66
shc [10], increased resistance to
oxidative stress might be a mechanism underlying the longer life
span.
The major part of serum IGF-I is liver-derived [24–26]. In
addition to regulation by GH [26], serum IGF-I levels are also
affected by food intake, exercise and age [26]. A mouse model with
liver-specific, inducible inactivation of the IGF-I gene, using the
Cre-LoxP conditional knockout system, has been developed (LI-
IGF-I
-/- mice) [24,26–30]. The selective inactivation of the IGF-I
gene in the liver results in a 75-80% reduction in serum IGF-I,
whereas the expression of IGF-I is unaffected in other tissues [24].
GH secretion is increased in LI-IGF-I
-/- mice secondary to a
decreased negative feedback by serum IGF-I [24,29].
Although LI-IGF-I
-/- mice have no major disturbance in
postnatal longitudinal bone growth [24], cortical bone mass is
clearly decreased [26,28,31]. Increased peripheral resistance in LI-
IGF-I
-/- mice results in elevated blood pressure [30]. Blood glucose
is normal but circulating levels of insulin and cholesterol are
increased [27]. The present study assessed the role of adult
expression of liver-derived IGF-I in life span, and also investigated
the importance of deficiency of liver-derived IGF-I for parameters
associated with life span including fertility, body composition,
oxygen consumption, activity level, food intake, and expression of
longevity-associated genes in several organs.
Results
Liver-specific inactivation of the IGF-I gene was induced in
mice at one month of age in most experiments. However, food
intake, body composition, oxygen consumption at rest, and activity
level were measured in mice that underwent inactivation of liver-
derived IGF-I at 12 months of age. In the experiments
determining life span, serum IGF-I was 32165 ng/ml in the
control mice (n=137) and 6263 ng/ml in the LI-IGF-I
-/- mice
(n=84), an 81% reduction (p,0.001). In all other experiments,
serum IGF-I concentration decreased approximately 80% in the
various groups of LI-IGF-I
-/- mice (p,0.001 in all experiments;
data not shown).
Body weight and life span
Body weight was measured every third month between 3 and 30
months of age. Reduced body weight was observed in both female
(Fig. 1A) and male (Fig. 1B) LI-IGF-I
-/- mice.
Mean life span increased 10% [LI-IGF-I
-/- mice (n=84):
24.760.6 months vs. control (n=137): 22.560.5 months, p,0.01
using unpaired t-test; Kaplan-Meier analysis: p=0.001, Cox’s
test], mainly due to increased life span (16%) in female mice [LI-
IGF-I
-/- mice (n=31): 26.761.1 vs. control (n=67): 23.060.7
months, p,0.01 using unpaired t-test; Kaplan-Meyer analysis
p,0.001, Cox’s test; Fig. 2A]. Male mice showed only a tendency
toward increased mean life span [6% increase; LI-IGF-I
-/- mice
(n=53): 23.560.8 vs. control (n=70): 22.160.7 months, p=0.17
using unpaired t-test; Kaplan-Meyer analysis p=0.10, Cox’s test;
Fig 2B].
Maximal life span of LI-IGF-I
-/- mice was not significantly
different compared to that of control mice (p=0.11). In male LI-
IGF-I
-/- mice, maximal life span was similar as that in control mice
(p=0.92) whereas in female LI-IGF-I
-/- mice, there was a non-
significant tendency to increased maximum life span. When 90%
of the joint distribution of female mice had died, 19% (6/31) of
female LI-IGF-I
-/- mice and 6% (4/67) of female control mice
were still alive (p=0.07).
Fertility
When 5- and 8-month-old female control and LI-IGF-I
-/- mice
were mated with male controls of similar age, the proportion of
pregnant females and the litter size were similar in both groups
(Fig. 3A and B). Similarly, when 5- and 8-month-old male control
and LI-IGF-I
-/- mice were mated with female controls of similar
age, the proportion of pregnant females and the litter size were
similar in both groups (data not shown).
Figure 1. Reduced body weight in LI-IGF-I
-/- mice. Body weight in A) female and B) male mice. Body weight was determined every third month
during 3-30 months of age. Between 3 and 27 months of age, body weight was significantly lower in LI-IGF-I
-/- compared with control mice in the
total number of mice and also in the male and female subgroups (all analyses p,0.001). The vertical bars indicate the SE for the mean values shown.
doi:10.1371/journal.pone.0022640.g001
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We previously demonstrated reduced body weight due to
reduced body fat in 13-month-old male and female LI-IGF-I
-/-
mice that underwent inactivation of liver-derived IGF-I at one
month of age [27]. The present study extends those findings by
investigating the effect of inactivation of IGF-I in hepatocytes at 12
months of age. Six months later, at 18 months of age,
measurements using dual-energy X-ray absorptiometry (DEXA)
showed reduced body fat also after correction for the reduced
body weight in the LI-IGF-I
-/- mice as compared with the control
mice (Table 1). Absolute values of lean mass was unchanged
whereas after correction for body weight, lean mass even increased
in the LI-IGF-I
-/- mice (Table 1). Dissections of fat pads showed
lower weight of inguinal, retroperitoneal, and gonadal fat in the
LI-IGF-I
-/- mice as compared with the control mice (Table 1).
Food intake, activity level, and oxygen consumption
We observed no differences in food intake, feces output, oxygen
consumption at rest, and spontaneous activity level while
measuring 13-month-old female mice when body weight was still
similar in both groups (Table 2). However, at 18 months, body
weight was reduced in the female LI-IGF-I
-/- mice compared with
the female control mice (p,0.001; data not shown). Additional
experiments to determine oxygen consumption during rest in 24-
month-old female control (n=8) and LI-IGF-I
-/- (n=5) mice that
underwent inactivation of liver-derived IGF-I at one month of age
showed no between-group difference (data not shown).
To further investigate mechanisms underlying reduced body fat
in LI-IGF-I
-/- mice, oxygen consumption during submaximal
exercise and post exercise was determined in 18-month-old female
control and LI-IGF-I
-/- mice that underwent inactivation of liver-
Figure 2. Increased mean life span of female LI-IGF-I
-/- mice. A) Female LI-IGF-I
-/- mice live 16% longer than female control mice (26.7 6 1.1 vs.
23.0 6 0.7 months, p,0.01 using unpaired t-test; Kaplan-Meyer analysis p,0.001, Cox’s test). B) Although not statistically significant, male LI-IGF-I
-/-
mice live 6% longer than male control mice (23.5 6 0.8 vs. 22.1 6 0.7 months, p=0.17 using unpaired t-test; Kaplan-Meyer analysis: p=0.10, Cox’s
test).
doi:10.1371/journal.pone.0022640.g002
Figure 3. Normal fertility in female LI-IGF-I
-/- mice. A) The percentage of pregnant female mice in relation to the total number of female mice in
each group. B) Litter size when female LI-IGF-I
-/- mice were mated with age-matched male control mice at 5 and 8 months of age (n=12-14 in each
group). The experiments showed normal fertility in female LI-IGF-I
-/- mice. In Figure 3B, the error bars indicate the standard error for the mean values
shown.
doi:10.1371/journal.pone.0022640.g003
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that oxygen consumption was increased during submaximal
exercise and post-exercise in LI-IGF-I
-/- mice compared with
controls (Fig. 4A). Respiratory exchange ratio (RER) was
unchanged (Fig. 4B).
Microarray analysis
We performed DNA microarray analyses in female control and
LI-IGF-I
-/- mice to identify possible mechanisms underlying
increased life span. We sought to determine whether there were
alterations in the global gene expression pattern that occurred
consistently in various tissues, including liver, skeletal muscle,
heart, fat (retroperitoneal fat) and bone (vertebrae). Four genes
were regulated according to the criteria described in Materials and
Methods (Table 3). Heat shock protein 1A (Hspa1a), heat shock
protein 1B (Hspa1b), and connective tissue growth factor (Ctgf)
were decreased in all organs that expressed these genes (Table 3).
CCAAT/enhancer protein delta (Cebpd) decreased in 4 of the 5
analyzed organs (Table 3). The expression of the IGF-I receptor
was unchanged in all organs studied (data not shown).
RT-PCR
To confirm the microarray findings, we performed RT-PCR
analyses on skeletal muscle (triceps) samples from individual mice.
The RT-PCR analyses confirmed that mRNA levels of Hspa1a
(Fig. 5A), Hspa1b (Fig. 5B), and Ctgf (Fig. 5C) decreased in LI-
IGF-I
-/- mice while mRNA levels of Cebpd were unchanged (data
not shown). The mRNA level of the IGF-I receptor was similar in
LI-IGF-I
-/- and control mice (Fig. 5D).
Discussion
This study shows that deficiency of liver-derived, endocrine
IGF-I results in increased mean life span. Mean life span increased
significantly in female LI-IGF-I
-/- mice and both genders
combined, while male LI-IGF-I
-/- mice showed only a tendency
for increased survival. Body weight decreased in LI-IGF-I
-/- mice
due to reduced fat mass. We observed no between-group
differences in fertility, food intake, and activity level, whereas
oxygen consumption during and after submaximal exercise was
increased in LI-IGF-I
-/- mice. Gene expression analyses of several
tissues in LI-IGF-I
-/- mice identified consistent regulation of three
transcripts (Hspa1a, Hspa1b, and Ctgf) that might be involved in
the aging process.
Low activity of IGF-I in nematodes [1,2], fruit flies [3,4], and
mice [5–8,15] results in increased life span. However, the role of
IGF-I in adult life is difficult to evaluate in these animals due to the
possible effect of absence of IGF-I activity during pre- and
postnatal development. Furthermore, these previous studies did
not evaluate the relative importance of liver-derived circulating
IGF-I vs. that of IGF-I produced in peripheral tissues. In LI-IGF-
I
-/- mice of this study, the deficiency of endocrine, liver-derived
IGF-I was induced at 1 or 12 months of age. Consequently, the
mice likely developed normally but then underwent a maintained,
selective inactivation of IGF-I in hepatocytes, but retained normal
IGF-I expression in the peripheral tissues as shown in several
previous studies [24,27–30,32–35]. Therefore, the present study is
the first to investigate life span in mice with normal IGF-I levels
during development.
The extension of mean life span in LI-IGF-I mice with
inactivation of liver-derived IGF-I was moderate (+10%), less
than that observed in GH-deficient Ames and Snell dwarf mice
[5,6]. However, in contrast to the long-lived dwarf mice,
longitudinal growth is almost normal in LI-IGF-I mice and body
weight decreases only moderately [24,27]. The results of some
studies suggest that the availability of food [36] and GH status [37]
during the first days or weeks of life can affect longevity in mice.
Therefore, unaffected IGF-I levels during the first month of life
before inactivation of liver-derived IGF-I could be of importance
for the less marked extension of mean life span in LI-IGF-I
-/- mice
compared to Ames and Snell dwarf mice that have low GH and
IGF-I levels also during early postnatal development [5,6].
Furthermore, the LI-IGF-I
-/- mice display compensatory increased
GH levels [geometric mean plasma GH concentration 3.1-fold
higher than that in control mice [24,26,29]]. This increased GH
secretion may exert a negative effect on life span in LI-IGF-I mice
and the full importance of liver-derived circulating IGF-I for life
span regulation is therefore difficult to evaluate. However, our
study shows that a marked reduction of liver-derived circulating
Table 1. Liver-derived IGF-I were inactivated at 12 months of
age.
Control mice LI-IGF-I
-/- mice P-value
Body weight (g) 39.9 (0.9) 30.0 (2.5) 0.01
DEXA
Body fat (g) 10.9 (1.9) 5.4 (1.2) ,0.05
Body fat (%) 29.3 (4.0) 18.9 (2.3) ,0.05
Lean mass (g) 24.4 (1.4) 21.3 (1.8) 0.22
Lean mass (%) 70.7 (4.0) 81.1 (2.3) ,0.05
Absolute weight of fat pads
Inguinal fat (g) 0.69 (0.07) 0.27 (0.10) 0.01
Retroperitoneal fat (g) 0.25 (0.05) 0.02 (0.01) ,0.01
Gonadal fat (g) 0.40 (0.15) 0.05 (0.03) ,0.05
Relative weight of fat pads
Inguinal fat (% of BW) 1.72 (0.16) 0.80 (0.25) ,0.05
Retroperitoneal fat (% of BW) 0.61 (0.13) 0.07 (0.02) ,0.01
Gonadal fat (% of BW) 0.99 (0.35) 0.15 (0.07) ,0.05
In control (n=6) and LI-IGF-I
-/- (n=8) mice, at 18 months of age, measurements
using DEXA and dissections of fat pads were performed. The DEXA scans were
from the lower level of the head to the inferior level of the first tail vertebra (the
maximal scan area of the DEXA). Values are given as means (SEM).
BW = body weight.
doi:10.1371/journal.pone.0022640.t001
Table 2. Liver-derived IGF-I were inactivated at 12 months of
age.
Control mice LI-IGF-I
-/- mice P-value
13-month-old female mice
Body weight (g) 38.8 (1.9) 38.6 (1.6) 0.94
Food intake 3.23 (0.28) 3.42 (0.24) 0.60
Feces output 1.26 (0.12) 1.25 (0.11) 0.95
Activity level (counts/min) 3.57 (0.51) 3.78 (0.55) 0.78
VO2 (ml/min/kg
0.75) 13.8 (0.9) 14.1 (0.5) 0.76
RER (VCO2/VO2) 0.70 (0.01) 0.71 (0.01) 0.17
At 13 months of age, before there was any difference in body weight, food
intake, feces output, activity level, and oxygen consumption at rest were
determined in female control (n=8) and LI-IGF-I
-/- (n=8) mice. Values are given
as means (SEM).
doi:10.1371/journal.pone.0022640.t002
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levels, results in a small but significant increase in mean life span.
Mean life span increased significantly (16%) in female LI-IGF-
I
-/- mice, while male LI-IGF-I
-/- mice showed only a non-
significant trend toward increased longevity. Similarly, life span in
Igf1r
+/- mice increased significantly only in female mice [8]. A
human study showed decreased body height and reduced activity
of the IGF-I receptor in female but not male offspring of long-lived
centenarians [38]. Furthermore, the consequences of low circu-
lating GH/IGF-I values differ considerably between men and
women with hypopituitary disease [39]. Therefore, the importance
of IGF-I for life span regulation appears to be partly gender-
dependent across species.
Reduced body weight in LI-IGF-I
-/- mice could be one
mechanism for prolonged life span in these mice. Previous studies
demonstrated gradually reduced body fat in LI-IGF-I
-/- mice, at
least partly mediated by the compensatory increase in GH
secretion [27]. In a previous study, body fat was unchanged after
correction for the reduced body weight in mice with deficiency of
liver-derived IGF-I [40]. In the present study, late inactivation of
liver-derived endocrine IGF-I (at 12 months of age) resulted in
reduced body weight and decreased body fat also after correction
for body weight. This late inactivation of IGF-I in hepatocytes may
resemble the age-related decline in serum IGF-I observed in
elderly humans more closely than early inactivation of liver-
derived IGF-I in previous mouse models.
We detected no between-group differences in food intake,
oxygen consumption at rest, or activity level, whereas oxygen
consumption during submaximal exercise was increased in LI-
IGF-I
-/- mice. We previously observed an association between
reduced energy expenditure during submaximal exercise and
subsequent body fat accumulation in mice with global deficiency
of interleukin-6 [41,42]. Furthermore, LI-IGF-I
-/- mice bear some
resemblance to fat-specific insulin receptor knockout (FIRKO)
mice, which display leanness, increased energy expenditure, and
enhanced longevity [43,44].
Since fertility of both male and female mice was similar to the
controls both in this study and a previous study of mice with
deficiency of liver-derived IGF-I [25], changes in fertility did not
cause increased mean life span in LI-IGF-I
-/- mice. Furthermore,
Figure 4. Increased oxygen consumption during submaximal exercise and post-exercise in LI-IGF-I
-/- mice. A) The volume of O2
consumed (VO2) and B) respiratory exchange ratio (RER) during submaximal exercise (30 min) and post-exercise (20 min) in 18-month-old female
control (n=7) and LI-IGF-I
-/- (n=7) mice. The vertical bars indicate the SE for the mean values shown. ** p,0.01 vs. control mice
doi:10.1371/journal.pone.0022640.g004
Table 3. Genes regulated in liver, skeletal muscle, heart, fat (retroperitoneal fat), and bone (vertebrae) in 7-month-old female
control (n=6) and LI-IGF-I
-/- (n=7) mice as determined by DNA microarray analyses.
Liver Muscle Heart Fat Bone
Gene title
Gene
symbol
GeneBank
Accession FC Exp FC Exp FC Exp FC Exp FC Exp
Heat shock protein 1A Hspa1a M12571 ND ND -2.48 ** -2.69 ** -2.30 ** -1.70 **
Heat shock protein 1B Hspa1b AF109906 -2.73 ** -2.53 ** ND ND -2.08 *** -1.51 **
Connective tissue
growth factor
Ctgf M70642 ND ND -2.12 ** -1.53 *** -2.79 ** -1.78 ***
CCAAT/
enhancer protein delta
(C/EBP delta)
Cebpd X61800 -2.41 * -2.06 *** NC ** -1.87 *** -1.57 **
The regulation of mRNA levels of different genes is indicated by the average-fold change (FC) according to the rules given in Materials and Methods.
Exp = Expression; *, 0–500; ** 501–2000; *** 2001–8000 (Arbitrary units by Affymetrix).
NC indicates no change (according to the rules given in Materials and Methods) and ND indicates not detectable.
doi:10.1371/journal.pone.0022640.t003
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increased longevity in the LI-IGF-I
-/- mice, because these mice
have increased blood pressure [30] and increased circulating
levels of insulin and cholesterol [27]. Insulin resistance and
hyperinsulinemia are associated with increased ROS formation, a
pro-inflammatory milieu, and a reduction of life span [23].
Impaired phosphoinositide 3-kinase pathway, decreased NAD-
dependent deacetylase sirtuin (Sirt) 1 activity, and telomere
shortening may mediate the reduction of life span in conditions of
hyperinsulinemia/insulin resistance [23]. Furthermore, increased
circulating levels of insulin may activate the IGF-I receptor [23].
In the present study, the mRNA level of the IGF-I receptor was
unchanged in LI-IGF-I
-/- mice in all organs studied using
microarray and in skeletal muscle as measured by RT-PCR. In
another mouse model of deficiency of liver-derived IGF-I with
approximately similar phenotype as that of LI-IGF-I
-/- mice
including insulin resistance [25,26], IGF-I receptor mRNA levels
were similar as those in control mice in multiple tissues [45].
Tyrosine phosphorylation state of the IGF-I receptor in skeletal
muscle was approximately similar in mice with deficiency of liver-
derived IGF-I and control mice before and after IGF-I
administration in one study [46], but otherwise little is known
of the extent to which the IGF-I receptor is activated in mice with
deficiency of liver-derived IGF-I. Therefore, the possibility
cannot be excluded that increased insulin levels in LI-IGF-I
-/-
mice, by an activation of the IGF-I receptor or by other effects,
could contribute to the less pronounced extension of life span in
these mice compared to Ames and Snell dwarf mice or Igf1r
+/2
mice.
Microarray analyses performed to identify genes regulated by
liver-derived IGF-I studied only female mice because mean life
span increased significantly in female but not male LI-IGF-I
-/-
mice. Since we sought transcripts that were consistently regulated
in several tissues, we analyzed tissue samples from liver, skeletal
muscle, heart, fat (retroperitoneal fat) and bone (vertebrae). Three
consistently regulated genes (Hspa1a, Hspa1b, and Ctgf) were
identified and confirmed by RT-PCR analyses.
The Hspa1a and Hspa1b genes of LI-IGF-I
-/- mice were
downregulated in all tissues that expressed these genes. Hspa1a
and Hspa1b encode members of the heat shock protein 70 (Hsp70)
family. Hsp70 proteins are stressed-induced chaperones involved
in cellular repair and maintenance mechanisms [47]. In Drosophila
melanogaster, experimentally induced overexpression of Hsp70
prolongs life span [48]. However, expression of endogenous
Hsp70 after heat stress exposure is reduced in long-lived Drosophila
melanogaster resistant to heat shock [49]. In humans, increased
Hsp70 expression has been implicated in the development of
atherosclerosis [50] and may also participate in the progression of
some cancers [51]. Therefore, drugs that modulate the heat shock
response are being developed [51]. In long-lived dwarf mice, the
regulation of heat shock proteins is complex and partly organ-
specific, but in accord with the present results, some in vitro and in
vivo data suggest reduced expression of heat shock proteins in
dwarf mice with low GH/IGF-I activity [52,53]. Therefore,
inhibition of genes encoding heat shock proteins may be of
importance for the increased life span of mice with low IGF-I
activity, which is in some accordance with the hypothesis that
longevity correlates with lower basal levels of heat shock protein
gene expression and more robust heat shock response [54]. An
effect of the GH/IGF-I axis on stress systems also somewhat
concurs with previous findings that nematodes and fruit flies
[17,22,23] as well as mouse strains with low IGF-I activity [8,10],
including mice with deficiency of liver-derived IGF-I [55], display
increased resistance to oxidative stress.
Figure 5. Decreased mRNA levels of Hspa1a, Hspa1b, and Ctgf in LI-IGF-I
-/- mice. To confirm the microarray findings, RT-PCR analyses were
performed on skeletal muscle (triceps) samples from individual mice. The RT-PCR analyses showed reduced mRNA levels of A) heat shock protein 1A
(Hspa1a), B) heat shock protein 1B (Hspa1b), and C) connective tissue growth factor (Ctgf). D) IGF-I receptor mRNA level was unchanged. The mRNA
levels in LI-IGF-I
-/- mice (n=7) are expressed as percent of that in control mice (n=6). The vertical bars indicate the SE for the mean values shown.
*p ,0.05 ** p,0.01 vs. control mice.
doi:10.1371/journal.pone.0022640.g005
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-/-
mice. Abnormal amplification of Ctgf-dependent signals results in
failure to terminate tissue repair, leading to pathological scarring
in conditions such as fibrosis and cancer [56]. It is well known that
GH treatment increases serum IGF-I level as well as collagen
formation [57]. Long-lived Snell dwarf mice with low GH/IGF-I
activity have delayed collagen aging in terms of age-dependent
collagen cross-linking [6]. Thus, inhibition of Ctgf expression by
deficiency of liver-derived endocrine IGF-I might delay aging, at
least in terms of collagen aging.
Mean life span was 22.5 months in the control mice, which is
approximately similar to the controls in Igf1r
+/2 mice studied by
Holzenberger et al. [8], but lower than that in wildtype C57Bl/6J
mice reported by the Jackson Laboratory (http://www.jax.org/).
The shorter life span in our control mice compared to wildtype
C57Bl/6J mice could be due to the genetic construction that the
control mice were carrying (exon 4 of the IGF-I gene flanked by
loxP sites) or due to differences in the environment or handling of
the mice. In the present study, necropsies were not performed.
However, in this as well as in our previous studies of LI-IGF-I
-/-
mice of various ages, we have not observed any signs of a specific
stress or disease in these mice [24,27–30,32–35].
In the previous study by Holzenberger et al., low IGF-I activity
in Igf1r
+/2 mice resulted in increased mean life span whereas the
effect on maximal life span was moderate [8]. In LI-IGF-I
-/- mice,
maximal lifespan was unaffected in the total group of mice and in
male mice and only non-significantly tended to be increased in
female mice. The possibility cannot be fully excluded that the
effect on maximal life span was small because deficiency of liver-
derived IGF-I only had a marginal effect on biological aging in late
life, and that increased mean life span in LI-IGF-I
-/- mice mainly
was due to increased resistance to stresses in their environment
during their entire life span.
In conclusion, adult inactivation of liver-derived, endocrine IGF-
I results in a modest but significant increase in mean life span, an
effect that is more predominant in female than male LI-IGF-I
-/-
mice. A contributing mechanism for the increased mean life span
mightbereducedbodyweightduetoreduced bodyfat,whichmight
partly result from increased energy expenditure during exercise. A
consistent regulation of three genes in several tissues might directly
or indirectly be of importance for the increased longevity in LI-IGF-
I
-/- mice by modulating stress response and collagen aging.
Materials and Methods
Animals and serum IGF-I
The LI-IGF-I
-/- mice were generated as described previously
(C57BL/6 background) [24,27–30]. Mice homozygous for LoxP
[58] and heterozygous for Mx-Cre [59] received three ip injections
of polyinosinic-polycytidylic acid (PiPc; 6.25 mg/g body weight;
Sigma-Aldrich Corp., Stockholm, Sweden) to induce expression of
the Cre protein, thereby inactivating the IGF-I gene in the liver
[59]. This treatment was given at one month of age to study life
span, fertility, oxygen consumption at submaximal exercise, and
gene expression, or at 12 months of age to measure food intake,
oxygen consumption at rest, activity level, and body composition.
PiPc-treated littermates, homozygous for LoxP but lacking Mx-
Cre, were used as controls. Seven days after the PiPc injections,
serum was obtained and assayed for IGF-I by a double-antibody
IGF-binding protein-blocked RIA (Mediagnost, Tu ¨bingen, Ger-
many). The animals had free access to fresh water and food pellets
(B&K Universal AB, Sollentuna, Sweden). The ethical committee
at the University of Gothenburg approved this study. Ethical
approval number: 92-2004.
Study design
Body weight and life span were determined in 137 (67 female
and 70 male) control mice and 84 (31 female and 53 male) LI-IGF-
I
-/- mice. Fertility was determined in 5- and 8-month-old female
and male control and LI-IGF-I
-/- mice (n=12–14 in each group).
Energy expenditure was assessed in 24-month-old female control
(n=8) and LI-IGF-I
-/- (n=5) mice and during submaximal
exercise in 18-month-old female control (n=7) and LI-IGF-I
-/-
(n=7) mice. Microarray analyses of gene expression in liver,
skeletal muscle, heart, fat, and bone (vertebrae) were performed in
female control (n=6) and LI-IGF-I
-/- (n=7) mice.
In additional experiments, liver-derived IGF-I was inactivated
at 12 months of age. This late inactivation of IGF-I in hepatocytes
resemble the age-related decline in serum IGF-I observed in
elderly humans more closely than inactivation of liver-derived
IGF-I in early adult life. Food intake, indirect calorimetry at rest,
and spontaneous activity level were assessed in 13-month-old
female control (n=8) and LI-IGF-I
-/- (n=8) mice one month
following inactivation of liver-derived IGF-I and before there was
any between-group difference in body weight. Dual-energy X-ray
absorptiometry (DEXA) determined body composition in male
control (n=8) and LI-IGF-I
-/- (n=6) mice at 18 months of age, 6
months following inactivation of liver-derived IGF-I at 12 months
of age, and weights of fat pads were also determined.
Fertility, body composition and food consumption
Fertility was assessed by mating female or male LI-IGF-I mice
with control mice of opposite gender and the proportion of
pregnant female mice and the litter size were determined.
Body composition was assessed using dual-energy X-ray
absorptiometry (DEXA; PIXImus, Lunar Corporation, Madison,
Michigan, USA). Total body fat and total body lean mass were
measured from the lower level of the head to the inferior level of
the first tail vertebra (the maximal scan area of the DEXA). Food
intake and feces output were measured every 24 hours while mice
were kept individually in metabolic cages for 5 days with free
access to chow and drinking water, and the 3 last days were used
for analyses.
Activity measurement and indirect calorimetry
Mice were housed in separate chambers during these experi-
ments. Spontaneous physical activity was measured using a
photocell-based activity monitor (Opto-Max; Columbus Instru-
ments, Columbus, OH). Interruption of four infrared photocells
on the short side and eight photocells on the long side of the cage
recorded the activity. Broken beams were recorded every 30
seconds for 2 hours, and the last hour was used for analysis.
The volume of O2 consumed (VO2) and CO2 produced (VCO2)
were measured by an Oxymax system (Columbus Instruments) for
120 min at 30uC (thermoneutrality). A steady-state was reached
after 90 min and the following 30 min between 90 and 120 min
were used for analysis. VCO2 and VO2 were measured every sixth
min as the mean of every second measurement. Respiratory
exchange ratio (RER) was measured as the ratio of VCO2 to VO2.
Energy expenditure during submaximal exercise
Mice were exercised on a motorized treadmill (Columbus
Instruments) with an adjustable belt speed (0–100 m/min) and
inclination (210u to 25u). The treadmill was connected to the
Oxymax system (Columbus Instruments) for measurement of
energy expenditure by indirect calorimetry. The mice were
encouraged to run by gentle tapping on their back. Before the
experiments, all mice were acclimatized to the treadmill during a
Endocrine IGF-I and Life Span
PLoS ONE | www.plosone.org 7 July 2011 | Volume 6 | Issue 7 | e226403-day period with 5 min of rest and 5 min of running at 10 m/
min and 0u inclination each day. On the test day, the mice rested
for 1–2 h in the treadmill at room temperature (23uC) and then
ran at a fixed speed of 10 m/min with an inclination of 0u for
30 min, followed by a 20 min post-exercise rest period.
DNA microarray analysis and bioinformatics
RNA from liver, skeletal muscle, heart, fat (retroperitoneal fat)
and bone (vertebrae) was extracted from 6 control and 7 LI-IGF-
I
-/- mice by Tri Reagent (Sigma, St. Louis, MO, USA) and
purified using spin columns from Rneasy Total RNA Isolation Kit
(Qiagen, Chatsworth, CA, USA). For microarray analysis, the
RNA samples were pooled three or two, resulting in three pools
per group while for the confirmatory RT-PCR analyses individual
mice (n=6–7) were analyzed. The pooled RNA was reverse
transcribed into cDNA, labeled, and analyzed by DNA microarray
(MG-U74Av2 Array; Affymetrix, Santa Clara, CA, USA). The
microarray data is MIAME compliant and can be accessed at
EMBL-EBI ArrayExpress repository, ArrayExpress accession: E-
MEXP-3026.
Scanned output files were analyzed using Affymetrix Micro
Array Suite version 4.0.1 software (Affymetrix). To allow
comparison of gene expression, the gene chips were globally
scaled to an average intensity of 500. Each of the three LI-IGF-I
-/-
chips was compared with the three control chips, generating a total
of nine comparison files. Only the genes that were regarded as
‘‘changed’’ according to the Affymetrix algorithm in four to nine
of the comparisons were selected for further analysis. We then
calculated an average-fold change for the nine comparisons of the
selected genes. For a gene to be regarded as consistently regulated
in the LI-IGF-I
-/- mice, the average-fold increase or decrease of
the nine comparisons was set as at least 1.5 fold in at least 4 of the
5 analyzed organs.
Real-time PCR analysis
To confirm the microarray findings, we performed RT-PCR
analyses on skeletal muscle (triceps) samples from individual mice
(n=6–7) (ABI Prism 7700 Sequence Detection System (PE Applied
Biosystems, Stockholm, Sweden). We used FAM-labeled probes
specific for heat shock protein 1A (Mm01159846_s1) and 1B
(Mm03038954_s1), connective tissue growth factor (Mm01192-
931_g1), CCAAT/enhancer protein delta (Mm00514291_s1), and
IGF-I receptor (Mm00802831_m1). The reporter fluorescent dye
VIC, specific for 18S rRNA, was included as an internal standard.
The cDNA was amplified at 1 cycle at 50 C for 2 min and 95 C for
10 min, followed by 40 cycles at 95 C for 15 sec and 60 C for 1 min.
We calculated the mRNA amount of each gene using the standard
curve method (multiplex reaction, User Bulletin no. 2, PE Applied
Biosystems).
Statistical analyses
All descriptive statistical results are presented as the mean 6
SEM. Between-group differences were calculated using unpaired t-
tests. Differences between survival curves were determined using
Cox’s test. Maximum lifespan was calculated as the number of
mice that were alive (and number dead) at the age at which 90% of
the joint distribution (LI-IGF-I
-/- plus control mice) had died
[60,61]. A two-tailed p,0.05 was considered significant.
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